Currently out of the existing stock ratings of Steven Mah, 112 are a BUY (89.6%), 13 are a HOLD (10.4%).

Steven Mah

Work Performance Price Targets & Ratings Chart

Analyst Steven Mah, carries an average stock price target met ratio of 49.51% that have a potential upside of 28.2% achieved within 177 days. Previously, Steven Mah worked at TD COWEN.

Steven Mah’s has documented 242 price targets and ratings displayed on 27 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on TWST, Twist Bioscience Corp at 04-Aug-2025.

Wall Street Analyst Steven Mah

Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/9/2021. The price target of $255 was fulfilled within 6 days with a profit of $63.6 (33.23%) receiving and performance score of 55.38.

Average potential price target upside

of $50.64 (16.35%) on ILMN (ILLUMINA).
of $38.78 (22.38%) on TLIS (TALIS BIOMEDICAL CORP).
of $30.31 (84.6%) on FLGT (FULGENT GENETICS).

AKYA Akoya Biosciences CDXS Codexis HSKA Heska ILMN Illumina NTRA Natera OXFD Oxford Immunotec Global PLC PROG Progenity TLIS Talis Biomedical Corp TWST Twist Bioscience Corp VIVO Meridian Bioscience DNA Ginkgo Bioworks Holdings FLDM Fluidigm LMNX Luminex OCDX Ortho Clinical Diagnostics Holdings plc CDNA Caredx FLGT Fulgent Genetics OCX OncoCyte Corp PACB Pacific Biosciences of California QDEL Quidel AVTR Avantor AXDX Accelerate Diagnostics ME 23Andme Holding Co BLFS BioLife Solutions LAB Standard Biotools ABCL Abcellera Biologics ABSI Absci Corp SDGR Schrodinger

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kyle Mikson (CANACCORD)